Aurinia Pharmaceuticals Inc

(NASDAQ:AUPH)

Latest On Aurinia Pharmaceuticals Inc (AUPH):

Date/Time Type Description Signal Details
2023-05-22 04:58 ESTNewsAurinia: Despite Milder Shareholder Vote, A Bid To Sell Is Still Not OverN/A
2023-05-18 03:27 ESTNewsAurinia Pharmaceuticals gains as two board members resign amid holder voteN/A
2023-05-11 16:54 ESTNewsAurinia Pharma's largest holder to oppose seven director nominationsN/A
2023-05-04 22:29 ESTNewsAurinia Pharmaceuticals Inc. (AUPH) Q1 2023 Earnings Call TranscriptN/A
2023-05-04 09:27 ESTNewsAurinia Pharma GAAP EPS of -$0.18 beats by $0.04, revenue of $34.41M beats by $6.29MN/A
2023-05-04 09:27 ESTNewsAurinia Pharma gains after Q1 beat and guidance raiseN/A
2023-05-03 21:13 ESTNewsAurinia wins U.K. nod for lupus nephritis therapy LupkynisN/A
2023-05-03 21:13 ESTNewsAurinia Pharma Q1 2023 Earnings PreviewN/A
2023-04-24 15:43 ESTNewsAurinia Pharma shareholder says company should put itself up for saleN/A
2023-04-05 19:20 ESTNewsAurinia's Lupkynis shows promise in 18-month kidney biopsy dataN/A
2023-03-24 07:05 ESTNewsAurinia Pharmaceuticals gains amid renewed takeover speculationN/A
2023-03-24 07:05 ESTNewsAurinia Pharmaceuticals: All In On Lupkynis - A Tough BetN/A
2023-03-24 07:05 ESTNewsAurinia Pharmaceuticals: Some Improvement In Topline, But A Buyout Alone Will Unlock ValueN/A
2023-03-23 15:36 ESTNewsAurinia Pharmaceuticals Has Strong Upside PotentialN/A
2023-03-22 08:08 ESTNewsAurinia Pharmaceuticals' Lupkynis Faces Challenges In Lupus Nephritis MarketN/A
2023-02-28 16:56 ESTNewsAurinia Pharma reports mixed Q4 earnings; reaffirms FY23 outlookN/A
2023-02-28 16:56 ESTNewsAurinia stock rises as Q4 loss narrows, Lupkynis revenue grows; reaffirms product outlookN/A
2023-02-28 16:56 ESTNewsAurinia Pharmaceuticals Inc. (AUPH) Q4 2022 Earnings Call TranscriptN/A
2023-02-28 01:47 ESTNewsAurinia Pharma Q4 2022 Earnings PreviewN/A
2023-01-25 14:02 ESTNewsAurinia adds 11% amid patent wins in the U.S. and EUN/A
2023-01-06 09:17 ESTNewsAurinia Pharmaceuticals guides Q4 revenue above estimatesN/A
2023-01-05 20:19 ESTNewsAurinia Pharmaceuticals: Lupkynis Patent Settlement Removes OverhangN/A
2023-01-05 20:19 ESTNewsAurinia's Patent Dispute Is Over, But Without A Buyout, There's No UpsideN/A
2023-01-04 16:36 ESTNewsAurinia Pharmaceuticals gains amid M&A speculation following patent settlementN/A
2023-01-03 13:05 ESTNewsAurinia shares jump 36% on patent challenge settlement with India's Sun PharmaN/A
2022-12-01 07:15 ESTNewsAurinia's lupus nephritis drug Lupkynis gets approval in UKN/A
2022-11-06 23:23 ESTNewsAurinia: A Commercial Stage Company With Major HeadwindsN/A
2022-11-03 23:28 ESTNewsAurinia Pharma GAAP EPS of -$0.06 beats by $0.13, revenue of $55.78M beats by $19.38MN/A
2022-11-03 23:28 ESTNewsAurinia sheds 22% as lackluster Lupkynis uptake leads to guidance cutN/A
2022-11-03 23:28 ESTNewsAurinia Pharmaceuticals Inc. (AUPH) Q3 2022 Earnings Call TranscriptN/A
2022-11-02 13:46 ESTNewsAurinia Pharma Q3 2022 Earnings PreviewN/A
2022-10-21 20:09 ESTNewsAurinia announces resignations of medical chief and senior research executiveN/A
2022-10-21 20:09 ESTNewsAurinia defended at H.C. Wainwright after key resignationsN/A
2022-09-19 19:15 ESTNewsAurinia Pharmaceuticals wins European approval of Lupkynis for lupusN/A
2022-08-24 17:12 ESTNewsAurinia Pharmaceuticals: The Right Play NowN/A
2022-08-16 04:35 ESTNewsAurinia Pharmaceuticals: Updating My Revenue And Valuation ModelN/A
2022-08-04 23:37 ESTNewsAurinia Pharmaceuticals Inc's (AUPH) CEO Peter Greenleaf on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-04 08:03 ESTNewsAurinia Pharma GAAP EPS of -$0.25 misses by $0.03, revenue of $28.2M beats by $1.16MN/A
2022-08-04 08:02 ESTNewsAurinia narrows 2Q net loss as Lupkynis sales regain momentumN/A
2022-08-03 17:35 ESTNewsAurinia Pharma Q2 2022 Earnings PreviewN/A
2022-07-26 13:19 ESTNewsPatent challenge on Aurinia's Lupkynis could impact takeover interest near-term - CantorN/A
2022-07-22 12:15 ESTNewsAurinia lupus nephritis drug recommended in EuropeN/A
2022-07-16 02:36 ESTNewsAurinia Pharma tumbles after takeover speculation cools on new exec hires, exec departureN/A
2022-07-04 17:27 ESTNewsA Buyout-Driven Pair Trade: Buy Aurinia, Sell Merck (Or Seagen If You Must)N/A
2022-07-01 19:17 ESTNewsAurinia Pharmaceuticals gains on speculation of Otsuka interestN/A
2022-05-24 14:21 ESTNewsAurinia Pharmaceuticals: Some Red Flags To Consider From Q1 2022 EarningsN/A
2022-05-22 11:59 ESTNewsAurinia: Redemption On Lupkynis Sales And Possible EMA ApprovalN/A
2022-05-20 13:35 ESTNewsAurinia Pharmaceuticals touts long-term benefit of Lupkynis for lupusN/A
2022-05-11 00:20 ESTNewsAurinia Pharma GAAP EPS of -$0.27 in-line, revenue of $21.63M beats by $2.39MN/A
2022-05-11 00:20 ESTNewsAurinia Pharma in focus despite 1Q revenue beat as Omicron hurts Lupkynis salesN/A

About Aurinia Pharmaceuticals Inc (AUPH):

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.

AUPH Quotes by TradingView

See Advanced Chart

General

  • Name Aurinia Pharmaceuticals Inc
  • Symbol AUPH
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 294
  • Last Split Factor1:50
  • Last Split Date2013-10-23
  • Fiscal Year EndDecember
  • IPO Date1999-01-26
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.auriniapharma.com
View More

Valuation

  • Forward PE 1428.57
  • Price/Sales (Trailing 12 Mt.) 33.99
  • Price/Book (Most Recent Quarter) 4.49
  • Enterprise Value Revenue 28.78
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Profit Margin -205%
  • Operating Margin -208%
  • Return on Assets -17%
  • Return on Equity -29%
  • Revenue 50.12 million
  • Earnings Per Share -$0.70
  • Revenue Per Share $0.42
  • Gross Profit -209000
  • Quarterly Earnings Growth 172417.2%
View More

Highlights

  • Market Capitalization 1.72 billion
  • EBITDA -58641000
  • Analyst Target Price $11.5
  • Book Value Per Share $3.22
View More

Share Statistics

  • Shares Outstanding 127.45 million
  • Shares Float 116.02 million
  • % Held by Insiders 978%
  • % Held by Institutions 55.87%
  • Shares Short 5.95 million
  • Shares Short Prior Month 5.44 million
  • Short Ratio 1.21
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 0.47
  • 52 Week High $18.72
  • 52 Week Low $11.3
  • 50 Day Moving Average 14.98
  • 200 Day Moving Average 14.65
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Aurinia Pharmaceuticals Inc (AUPH) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Aurinia Pharmaceuticals Inc (AUPH) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-24$50.03 million-$0.05-$0.2075.16%
2020-09-302020-11-10$N/A-$0.28-$0.24-19.15%
2020-06-302020-08-11$N/A-$0.26-$0.23-12.51%
2020-03-312020-05-14$30000-$0.15-$0.2743.93%
2019-12-312020-03-05$29000-$0.78-$0.20-281.79%
2019-09-302019-11-14$230000-$0.21-$0.19-11.52%
2019-06-302019-08-06$29000-$0.17-$0.16-7.59%
2019-03-312019-05-14$30000-$0.14-$0.154.11%
2018-12-312019-03-19$29000-$0.17-$0.16-6.25%
2018-09-302018-11-08$375000-$0.21-$0.18-17.98%
2018-06-302018-08-09$29000-$0.19-$0.14-31.94%
2018-03-312018-05-10$30000-$0.18-$0.16-13.71%
2017-12-312018-03-15$31000-$0.04-$0.1471.77%
2017-09-302017-11-14$29000-$0.16-$0.14-11.11%
2017-06-302017-08-10$329000-$0.03-$0.1376.92%
2017-03-312017-05-15$31000-$0.92-$0.12-693.1%
2016-12-312017-03-09$30000-$0.21-$0.11-85.35%
2016-09-302016-11-04$31000-$0.21-$0.15-42.37%
2016-06-302016-08-05$55000-$0.10-$0.116.28%
2016-03-312016-05-11$57000-$0.13-$0.147.14%
2015-12-312016-03-18$57000-$0.13-$0.143.7%
2015-09-302015-11-13$57000-$0.16-$0.2227.27%
2015-06-302015-08-04$59000-$0.02-$0.2090%
2015-03-312015-05-15$62000-$0.27-$0.14-92.86%
2014-12-312015-03-30$68000-$0.15-$0.12-25%
2014-09-302014-11-12$72000-$0.08
2014-06-302014-08-15$71000-$0.13
2014-03-312014-05-16$67000-$0.24
2013-12-312014-03-28$702249.84$0.11
2013-09-302013-11-22$84384.09-$0.45
2013-06-302013-08-14$83833.48-$0.25
2013-03-312013-05-16$87529.5-$0.20
2012-09-302012-11-14$87549.63-$0.49
2008-12-312009-03-27$585963.18-$2.50-$2.00-25%
2008-09-302008-11-14$2.69 million-$2.00-$2.5020%
2008-06-302008-08-06$553324.85-$2.50-$2.500%
2008-03-312008-05-06$564272.49-$2.50-$4.0037.5%
2007-12-312008-03-18$608006.42-$4.00-$4.5011.11%
2007-09-302007-11-06$554715.08-$3.50-$4.8327.54%
2007-06-302007-08-14$432601.29-$4.50-$4.500%
2007-03-312007-05-09$604253.11-$4.00-$4.7515.79%
2006-12-312007-03-16$759070.25-$4.50-$4.836.83%
2006-09-302006-11-14$519853.01-$4.00-$4.5011.11%
2006-06-302006-08-03$935374.15-$4.00-$4.000%
2006-03-312006-05-15$1.37 million-$3.00-$6.5053.85%
2005-12-312006-03-14$367924.53-$5.50-$4.57-20.35%
2005-09-302005-11-04$262185.16-$4.00-$3.00-33.33%
2005-06-302005-08-09$203998.37-$5.50-$6.5015.38%
2005-03-312005-05-13$317539.07-$5.50-$7.0021.43%
2004-12-312005-03-02$205320.03-$6.50-$6.500%
2004-09-302004-11-10$262261.31-$6.00-$6.000%
2004-06-302004-08-10$255063.77-$3.00-$3.257.69%
2004-03-312004-05-13$468046.12-$2.50-$4.0037.5%
2003-12-312004-03-29$314572.09-$5.50-$3.50-57.14%
2003-09-302003-11-25$306771.14-$4.00-$3.75-6.67%
2003-06-302003-08-25$6.53 million$1.00$3.00-66.67%
2003-03-312003-05-23$215925.35-$4.50-$3.00-50%
2002-12-312003-03-11$206650.98-$3.50-$2.00-75%
2002-09-302002-11-26$4.19 million$3.00$0.00

Aurinia Pharmaceuticals Inc (AUPH) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Aurinia Pharmaceuticals Inc (AUPH) Chart:

Aurinia Pharmaceuticals Inc (AUPH) News:

Below you will find a list of latest news for Aurinia Pharmaceuticals Inc (AUPH) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Aurinia Pharmaceuticals Inc (AUPH) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-1710CALL0 00TRUE00
2024-05-1720CALL0 0566.34TRUE00
2024-05-1732.01CALL0 20300.38TRUE00
2024-05-1741.1CALL0 26123.93TRUE00
2024-05-1750.47CALL10 125982.32TRUE0.020.04
2024-05-1760.18CALL73 136991.52FALSE0.020.13
2024-05-1770.08CALL3 421102.07FALSE0.020.33
2024-05-1780.05CALL31 1405116.47FALSE00
2024-05-1790.07CALL0 20FALSE00
2024-05-17100.05CALL0 120FALSE00
2024-05-1710PUT0 00FALSE00
2024-05-1720PUT0 00FALSE00
2024-05-1730PUT0 00FALSE00
2024-05-1740.18PUT2 59126.38FALSE0.132.6
2024-05-1750.44PUT24 32197.49FALSE0.050.13
2024-05-1761.15PUT0 3291.92TRUE00
2024-05-1771.95PUT0 35228.11TRUE00
2024-05-1780PUT0 0165.21TRUE00
2024-05-1790PUT0 0183.59TRUE00
2024-05-17100PUT0 0221.9TRUE00
2024-06-2110CALL0 00TRUE00
2024-06-2120CALL0 00TRUE00
2024-06-2130CALL0 0186.89TRUE00
2024-06-2140CALL0 0115.13TRUE00
2024-06-2150.6CALL25 1366.63TRUE0.010.02
2024-06-2160.29CALL15 3371.94FALSE0.040.16
2024-06-2170.13CALL0 2472.76FALSE00
2024-06-2180.05CALL0 286.1FALSE00
2024-06-2190CALL0 00FALSE00
2024-06-21100CALL0 00FALSE00
2024-06-2110PUT0 00FALSE00
2024-06-2120PUT0 00FALSE00
2024-06-2130.07PUT0 100FALSE00
2024-06-2140.22PUT0 10267.6FALSE00
2024-06-2150.5PUT0 270.47FALSE00
2024-06-2161.38PUT0 267.61TRUE00
2024-06-2170PUT0 087.51TRUE00
2024-06-2180PUT0 093.87TRUE00
2024-06-2190PUT0 0209.35TRUE00
2024-06-21100PUT0 0219.64TRUE00
2024-07-1914.7CALL0 10TRUE00
2024-07-1923.2CALL0 21210.1TRUE00
2024-07-1932.05CALL0 092.92TRUE00
2024-07-1941.3CALL0 571.46TRUE00
2024-07-1950.75CALL5 42669.36TRUE0.10.15
2024-07-1960.37CALL1 175567.02FALSE0.370
2024-07-1970.2CALL3 187469.91FALSE00
2024-07-1980.15CALL100 293678.91FALSE0.150
2024-07-1990.1CALL8 130382.63FALSE0.10
2024-07-19100.05CALL0 137287.32FALSE00
2024-07-19110.1CALL0 3740FALSE00
2024-07-19120.17CALL0 2550FALSE00
2024-07-19130.1CALL0 8990FALSE00
2024-07-19140.05CALL0 1220FALSE00
2024-07-19150.1CALL0 3630FALSE00
2024-07-19160.05CALL0 110FALSE00
2024-07-1910PUT0 00FALSE00
2024-07-1920.05PUT0 100FALSE00
2024-07-1930.13PUT0 50FALSE00
2024-07-1940.25PUT0 10673.72FALSE00
2024-07-1950.55PUT4 353964.05FALSE0.550
2024-07-1961.45PUT0 30970.69TRUE00
2024-07-1972.25PUT0 35580.38TRUE00
2024-07-1983.1PUT0 31769.91TRUE00
2024-07-1994.07PUT0 78135.75TRUE00
2024-07-19105.01PUT0 732136.62TRUE00
2024-07-19110PUT0 0167.07TRUE00
2024-07-19126.6PUT0 0171.43TRUE00
2024-07-19137PUT0 0160.51TRUE00
2024-07-19140PUT0 0142.41TRUE00
2024-07-19159PUT0 0149.72TRUE00
2024-07-191610.76PUT0 0183.52TRUE00
2024-10-1810CALL0 0222.78TRUE00
2024-10-1823.7CALL0 5276.95TRUE00
2024-10-1832.45CALL0 2115.68TRUE00
2024-10-1841.44CALL0 1345.55TRUE00
2024-10-1851.01CALL0 5970.18TRUE00
2024-10-1860.6CALL0 145570.59FALSE00
2024-10-1870.4CALL42 4564.13FALSE0.40
2024-10-1880.25CALL0 8270.63FALSE00
2024-10-1890.2CALL0 1368.68FALSE00
2024-10-18100.2CALL0 5570.87FALSE00
2024-10-18110.07CALL0 3370.46FALSE00
2024-10-18120.28CALL0 50FALSE00
2024-10-18130CALL0 00FALSE00
2024-10-18140CALL0 00FALSE00
2024-10-18150CALL0 00FALSE00
2024-10-18160CALL0 00FALSE00
2024-10-1810PUT0 00FALSE00
2024-10-1820.14PUT10 10116.2FALSE-0.01-0.07
2024-10-1830.24PUT10 1175.5FALSE-0.01-0.04
2024-10-1840.42PUT0 372.72FALSE00
2024-10-1850.8PUT10 7765.16FALSE0.80
2024-10-1861.7PUT0 61170.34TRUE00
2024-10-1872.32PUT0 1355.63TRUE00
2024-10-1883.1PUT0 2966.31TRUE00
2024-10-1893.72PUT0 1071.36TRUE00
2024-10-18104.88PUT0 30280.44TRUE00
2024-10-18115.35PUT0 0134.61TRUE00
2024-10-18127PUT0 087.75TRUE00
2024-10-18137.81PUT0 0141.85TRUE00
2024-10-18148.1PUT0 0108.32TRUE00
2024-10-18159.2PUT0 0113.93TRUE00
2024-10-18160PUT0 0131.85TRUE00
2025-01-1720CALL0 0153.06TRUE00
2025-01-1732.44CALL0 12888.78TRUE00
2025-01-1740CALL0 075.02TRUE00
2025-01-1751.39CALL3 152674.76TRUE1.390
2025-01-1760.9CALL0 3990.81FALSE00
2025-01-1770.67CALL0 86566.11FALSE00
2025-01-1780.46CALL0 2066.33FALSE00
2025-01-17100.29CALL52 487069.03FALSE-0.01-0.03
2025-01-17120.17CALL4 106769.31FALSE0.010.06
2025-01-17150.15CALL0 66791.66FALSE00
2025-01-17170.05CALL0 8540FALSE00
2025-01-17200.09CALL0 301690.04FALSE00
2025-01-1720PUT0 00FALSE00
2025-01-1730.25PUT0 17574.98FALSE00
2025-01-1740PUT0 070.1FALSE00
2025-01-1751.2PUT0 37968.47FALSE00
2025-01-1760PUT0 068.13TRUE00
2025-01-1772.6PUT0 421264.52TRUE00
2025-01-1783.2PUT0 174.89TRUE00
2025-01-17105.1PUT0 28869.85TRUE00
2025-01-17126.7PUT0 500168.28TRUE00
2025-01-17159.8PUT0 198.89TRUE00
2025-01-171711PUT0 0107.67TRUE00
2025-01-172014PUT0 0119.02TRUE00
2026-01-1633CALL0 97111.65TRUE00
2026-01-1651.95CALL0 8663.04TRUE00
2026-01-1671.4CALL0 7367.47FALSE00
2026-01-16100.9CALL2 51968.36FALSE0.90
2026-01-16120.7CALL0 463.56FALSE00
2026-01-16150.5CALL0 26984FALSE00
2026-01-16170.8CALL0 1310FALSE00
2026-01-16200.56CALL0 1840FALSE00
2026-01-1630.54PUT0 2875.03FALSE00
2026-01-1651.56PUT0 34566.73FALSE00
2026-01-1672.9PUT0 123270.42TRUE00
2026-01-16105.35PUT0 3364.79TRUE00
2026-01-16126.98PUT0 2667.32TRUE00
2026-01-16159.8PUT7 12187TRUE9.80
2026-01-161711.17PUT0 0117.41TRUE00
2026-01-16200PUT0 092.13TRUE00

Latest AUPH Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$10.135
Jun 13, 2022 7:59 PM EST100$10.135
Jun 13, 2022 7:59 PM EST100$10.135
Jun 13, 2022 7:59 PM EST10$10.135
Jun 13, 2022 7:59 PM EST35$10.14

Aurinia Pharmaceuticals Inc (AUPH) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-26SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1600620/000119312520180928/0001193125-20-180928-index.htm
2018-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600620/000031506618001065/0000315066-18-001065-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600620/000031506619000891/0000315066-19-000891-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600620/000031506620000811/0000315066-20-000811-index.htm
2017-05-01SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000092189517001237/0000921895-17-001237-index.htm
2017-10-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000092189517002488/0000921895-17-002488-index.htm
2019-01-18SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000092189519000115/0000921895-19-000115-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600620/000108514620000766/0001085146-20-000766-index.htm
2019-04-08SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000110465919020260/0001104659-19-020260-index.htm
2019-06-04SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000110465919033560/0001104659-19-033560-index.htm
2019-11-13SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000110465919063369/0001104659-19-063369-index.htm
2019-12-06SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000110465919070670/0001104659-19-070670-index.htm
2019-12-09SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000110465919070762/0001104659-19-070762-index.htm
2019-12-10SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000110465919071472/0001104659-19-071472-index.htm
2019-12-18SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000110465919073834/0001104659-19-073834-index.htm
2020-01-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600620/000110465920007143/0001104659-20-007143-index.htm
2020-07-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000110465920086013/0001104659-20-086013-index.htm
2020-10-09SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000110465920113903/0001104659-20-113903-index.htm
2017-07-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600620/000114036117027184/0001140361-17-027184-index.htm
2017-04-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001041/0001157523-17-001041-index.htm
2017-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001103/0001157523-17-001103-index.htm
2017-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001104/0001157523-17-001104-index.htm
2017-05-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001401/0001157523-17-001401-index.htm
2017-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001558/0001157523-17-001558-index.htm
2017-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001561/0001157523-17-001561-index.htm
2017-05-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001643/0001157523-17-001643-index.htm
2017-06-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001712/0001157523-17-001712-index.htm
2017-06-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001796/0001157523-17-001796-index.htm
2017-06-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001833/0001157523-17-001833-index.htm
2017-07-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001937/0001157523-17-001937-index.htm
2017-08-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317002350/0001157523-17-002350-index.htm
2017-09-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317002443/0001157523-17-002443-index.htm
2017-09-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317002536/0001157523-17-002536-index.htm
2017-10-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317002726/0001157523-17-002726-index.htm
2017-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317003100/0001157523-17-003100-index.htm
2018-01-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318000022/0001157523-18-000022-index.htm
2018-02-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318000271/0001157523-18-000271-index.htm
2018-02-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318000404/0001157523-18-000404-index.htm
2018-03-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318000566/0001157523-18-000566-index.htm
2018-05-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318001088/0001157523-18-001088-index.htm
2018-06-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318001332/0001157523-18-001332-index.htm
2018-06-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318001334/0001157523-18-001334-index.htm
2018-07-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318001402/0001157523-18-001402-index.htm
2018-08-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318001785/0001157523-18-001785-index.htm
2018-09-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318001977/0001157523-18-001977-index.htm
2018-11-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318002387/0001157523-18-002387-index.htm
2019-01-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319000099/0001157523-19-000099-index.htm
2019-02-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319000428/0001157523-19-000428-index.htm
2019-02-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319000461/0001157523-19-000461-index.htm
2019-03-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319000601/0001157523-19-000601-index.htm
2019-03-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319000650/0001157523-19-000650-index.htm
2019-04-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319000799/0001157523-19-000799-index.htm
2019-04-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319000945/0001157523-19-000945-index.htm
2019-05-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319001193/0001157523-19-001193-index.htm
2019-05-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319001219/0001157523-19-001219-index.htm
2019-05-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319001334/0001157523-19-001334-index.htm
2019-06-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319001384/0001157523-19-001384-index.htm
2019-06-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319001414/0001157523-19-001414-index.htm
2019-06-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319001429/0001157523-19-001429-index.htm
2019-06-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319001445/0001157523-19-001445-index.htm
2019-07-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319001535/0001157523-19-001535-index.htm
2019-08-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319001723/0001157523-19-001723-index.htm
2019-10-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319002052/0001157523-19-002052-index.htm
2019-10-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319002143/0001157523-19-002143-index.htm
2019-11-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319002221/0001157523-19-002221-index.htm
2019-11-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319002261/0001157523-19-002261-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319002270/0001157523-19-002270-index.htm
2019-12-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319002316/0001157523-19-002316-index.htm
2019-12-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319002335/0001157523-19-002335-index.htm
2020-02-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000260/0001157523-20-000260-index.htm
2020-03-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000305/0001157523-20-000305-index.htm
2020-03-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000339/0001157523-20-000339-index.htm
2020-03-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000352/0001157523-20-000352-index.htm
2020-03-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000361/0001157523-20-000361-index.htm
2020-03-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000398/0001157523-20-000398-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000535/0001157523-20-000535-index.htm
2020-04-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000571/0001157523-20-000571-index.htm
2020-05-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000743/0001157523-20-000743-index.htm
2020-05-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000804/0001157523-20-000804-index.htm
2020-06-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000849/0001157523-20-000849-index.htm
2020-06-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000869/0001157523-20-000869-index.htm
2020-06-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000876/0001157523-20-000876-index.htm
2020-06-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000921/0001157523-20-000921-index.htm
2020-07-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001008/0001157523-20-001008-index.htm
2020-07-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001015/0001157523-20-001015-index.htm
2020-08-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001168/0001157523-20-001168-index.htm
2020-09-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001232/0001157523-20-001232-index.htm
2020-09-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001271/0001157523-20-001271-index.htm
2020-10-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001285/0001157523-20-001285-index.htm
2020-10-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001306/0001157523-20-001306-index.htm
2020-10-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001337/0001157523-20-001337-index.htm
2020-10-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001378/0001157523-20-001378-index.htm
2020-11-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001411/0001157523-20-001411-index.htm
2017-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312517169703/0001193125-17-169703-index.htm
2017-05-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312517176713/0001193125-17-176713-index.htm
2017-08-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312517254546/0001193125-17-254546-index.htm
2017-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312517342556/0001193125-17-342556-index.htm
2018-01-04F-10Registration Statement for Securities of certain Canadian Issuers.https://www.sec.gov/Archives/edgar/data/1600620/000119312518002955/0001193125-18-002955-index.htm
2018-01-04F-XAppointment of Agent for Service of Process and Undertakinghttps://www.sec.gov/Archives/edgar/data/1600620/000119312518003036/0001193125-18-003036-index.htm
2018-03-26F-10/ARegistration Statement for Securities of certain Canadian Issuers.https://www.sec.gov/Archives/edgar/data/1600620/000119312518096084/0001193125-18-096084-index.htm
2018-04-06SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1600620/000119312518108933/0001193125-18-108933-index.htm
2018-06-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1600620/000119312518188267/0001193125-18-188267-index.htm
2018-11-30SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1600620/000119312518339932/0001193125-18-339932-index.htm
2018-11-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312518339945/0001193125-18-339945-index.htm
2019-09-13SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1600620/000119312519244954/0001193125-19-244954-index.htm
2019-09-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312519244975/0001193125-19-244975-index.htm
2019-12-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312519308631/0001193125-19-308631-index.htm
2019-12-09SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1600620/000119312519308641/0001193125-19-308641-index.htm
2019-12-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312519309672/0001193125-19-309672-index.htm
2019-12-10SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1600620/000119312519310256/0001193125-19-310256-index.htm
2019-12-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312519312201/0001193125-19-312201-index.htm
2019-12-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312519316575/0001193125-19-316575-index.htm
2020-05-29F-10Registration Statement for Securities of certain Canadian Issuers.https://www.sec.gov/Archives/edgar/data/1600620/000119312520155700/0001193125-20-155700-index.htm
2020-05-29F-XAppointment of Agent for Service of Process and Undertakinghttps://www.sec.gov/Archives/edgar/data/1600620/000119312520155850/0001193125-20-155850-index.htm
2020-06-17F-10/ARegistration Statement for Securities of certain Canadian Issuers.https://www.sec.gov/Archives/edgar/data/1600620/000119312520171378/0001193125-20-171378-index.htm
2020-06-26SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1600620/000119312520180928/0001193125-20-180928-index.htm
2020-07-22SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1600620/000119312520197126/0001193125-20-197126-index.htm
2020-07-23SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1600620/000119312520197784/0001193125-20-197784-index.htm
2020-07-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312520197855/0001193125-20-197855-index.htm
2019-09-25SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600620/000121390019018908/0001213900-19-018908-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600620/000121390020003597/0001213900-20-003597-index.htm
2018-03-1540-FRegistration statement [Section 12] or Annual Report [Section 13(a), 15(d)]https://www.sec.gov/Archives/edgar/data/1600620/000162828018003228/0001628280-18-003228-index.htm
2018-05-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828018006544/0001628280-18-006544-index.htm
2018-05-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828018006852/0001628280-18-006852-index.htm
2018-05-176-K/AReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828018006878/0001628280-18-006878-index.htm
2018-08-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828018010933/0001628280-18-010933-index.htm
2018-11-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828018013983/0001628280-18-013983-index.htm
2019-03-1940-FRegistration statement [Section 12] or Annual Report [Section 13(a), 15(d)]https://www.sec.gov/Archives/edgar/data/1600620/000162828019003130/0001628280-19-003130-index.htm
2019-05-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828019006728/0001628280-19-006728-index.htm
2019-05-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828019007420/0001628280-19-007420-index.htm
2019-08-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828019010124/0001628280-19-010124-index.htm
2019-09-13S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1600620/000162828019011709/0001628280-19-011709-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828019014209/0001628280-19-014209-index.htm
2020-03-0540-FRegistration statement [Section 12] or Annual Report [Section 13(a), 15(d)]https://www.sec.gov/Archives/edgar/data/1600620/000162828020003036/0001628280-20-003036-index.htm
2020-04-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828020005759/0001628280-20-005759-index.htm
2020-05-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828020007783/0001628280-20-007783-index.htm
2020-06-09S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1600620/000162828020009166/0001628280-20-009166-index.htm
2020-08-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828020012430/0001628280-20-012430-index.htm
2018-03-29EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1600620/999999999518000708/9999999995-18-000708-index.htm
2020-06-19EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1600620/999999999520001488/9999999995-20-001488-index.htm